SINCE thorium dioxide solution was first used clinically by Radt (1), little has been learned about its rate of elimination from the body. We have been able to determine by roentgenograms that the liver and spleen retain some qualitatively large portion of the compound, but it is most logical that the radio-activity of the thorium series, which has engendered much of the prevalent suspicion of its physiological effects, should be chosen as an indicator for actual measurement of retention by the organism. The Geiger-Müller counter offers a sufficiently sensitive, simple, and rapid method for measuring such small intensities of radiation directly from the patient. Experimental work was, therefore, undertaken with this type of instrument to determine the average retention of intravenously administered thorium dioxide in the human organism. The absolute intensity of gamma radiation from fresh commercial thorotrast has been determined, in the course of our preliminary calibrations, to be equivalent to approximately 1.9 × 10−8 grams of radium per cubic centimeter. The factor is also substantiated by the recent work of Taft (2), whose measurements indicate a value of about 1.8 × 10−8. Although the radio-active life of thoriumin equilibrium with its decay products is far too great to be a perceptible factor in a clinical investigation, it has been shown that thorium dioxide as prepared commercially from thorium nitrate originally includes none of the decay series except radiothorium. From this beginning, the decay of the relatively short-lived radiothorium together with the natural production of mesothorium will combine to cause a fairly rapid change in the alpharay activity of the sample. According to the calculations of Schlundt1 and others, the alpha radiation from a given sample of freshly prepared ThO2 decreases by about half during the first five years, then gradually increases over a period of approximately thirty years to its original value. During this time, the gamma radiation, however, undergoes a much smaller variation. This gamma radiation, being the only portion which can penetrate through the abdominal wall, will of course constitute the portion measurable by external apparatus. Unfortunately, complete parallel history of the gamma-ray activity of thorium dioxide solution in vitro was not possible, since the data herewith submitted include patients who received thorium injections two or three years before the beginning of the experiment. During the few months over which actual measurements have been taken, original ampules of the thorium solution have maintained their gamma-ray activity constant within the experimental errors of the original reading. Since the inherent difficulty of such work with living patients precludes any high degree of accuracy, we have for the sake of simplicity assumed the gamma-ray intensity of ThO2 to be approximately constant over the four-year period covered by these data.